HIV Citation List: May 24 - June 6, 2013

PubMed citations

1. Microwave-assisted Combinatorial Synthesis of 2-Alkyl-2-(N-arylsulfonylindol- 3-yl)-3-N-acyl-5-aryl-1,3,4-oxadiazolines as anti-HIV-1 Agents. Che, Z.P., N. Huang, X. Yu, L.M. Yang, J.Q. Ran, X. Zhi, H. Xu, and Y.T. Zheng. Combinatorial Chemistry & High Throughput Screening, 2013. 16(5): p. 400-407. PMID[23176059].

[PubMed]. HIV_0524-060613.

2. Ledgins Inhibit Late Stage HIV-1 Replication by Modulating Integrase Multimerization in the Virions. Desimmie, B.A., R. Schrijvers, J. Demeulemeester, D. Borrenberghs, C. Weydert, W. Thys, S. Vets, B. Van Remoortel, J. Hofkens, J. De Rijck, J. Hendrix, N. Bannert, R. Gijsbers, F. Christ, and Z. Debyser. Retrovirology, 2013. 10(1): p. 57. PMID[23721378].

[PubMed]. HIV_0524-060613.

3. Restricting HIV-1 Pathways for Escape Using Rationally Designed anti-HIV-1 Antibodies. Diskin, R., F. Klein, J.A. Horwitz, A. Halper-Stromberg, D.N. Sather, P.M. Marcovecchio, T. Lee, A.P. West, Jr., H. Gao, M.S. Seaman, L. Stamatatos, M.C. Nussenzweig, and P.J. Bjorkman. The Journal of Experimental Medicine, 2013. [Epub ahead of print]. PMID[23712429].

[PubMed]. HIV_0524-060613.

4. Optimization of a 1,5-Dihydrobenzo[b][1,4]diazepine-2,4-dione Series of HIV Capsid Assembly Inhibitors 2: Structure-Activity Relationships (SAR) of the C3-phenyl Moiety. Fader, L.D., S. Landry, S. Goulet, S. Morin, S.H. Kawai, Y. Bousquet, I. Dion, O. Hucke, N. Goudreau, C.T. Lemke, J. Rancourt, P. Bonneau, S. Titolo, M. Amad, M. Garneau, J. Duan, S. Mason, and B. Simoneau. Bioorganic & Medicinal Chemistry Letters, 2013. 23(11): p. 3401-3405. PMID[23601710].

[PubMed]. HIV_0524-060613.

5. Optimization of a 1,5-Dihydrobenzo[b][1,4]diazepine-2,4-dione Series of HIV Capsid Assembly Inhibitors 1: Addressing Configurational Instability through Scaffold Modification. Fader, L.D., S. Landry, S. Morin, S.H. Kawai, Y. Bousquet, O. Hucke, N. Goudreau, C.T. Lemke, P. Bonneau, S. Titolo, S. Mason, and B. Simoneau. Bioorganic & Medicinal Chemistry Letters, 2013. 23(11): p. 3396-3400. PMID[23583513].

[PubMed]. HIV_0524-060613.

6. The Lantibiotic Peptide Labyrinthopeptin A1 Demonstrates Broad anti-HIV and anti-HSV Activity with Potential for Microbicidal Applications. Ferir, G., M.I. Petrova, G. Andrei, D. Huskens, B. Hoorelbeke, R. Snoeck, J. Vanderleyden, J. Balzarini, S. Bartoschek, M. Bronstrup, R.D. Sussmuth, and D. Schols. PLoS One, 2013. 8(5): p. e64010. PMID[23724015].

[PubMed]. HIV_0524-060613.

7. Development of a Fluorescence-based HIV-1 Integrase DNA Binding Assay for Identification of Novel HIV-1 Integrase Inhibitors. Han, Y.S., W.L. Xiao, P.K. Quashie, T. Mesplede, H. Xu, E. Deprez, O. Delelis, J.X. Pu, H.D. Sun, and M.A. Wainberg. Antiviral Research, 2013. 98(3): p. 441-448. PMID[23583286].

[PubMed]. HIV_0524-060613.

8. Indolizine Derivatives as HIV-1 VIF-elonginC Interaction Inhibitors. Huang, W., T. Zuo, X. Luo, H. Jin, Z. Liu, Z. Yang, X. Yu, L. Zhang, and L. Zhang. Chemical Biology & Drug Design, 2013. 81(6): p. 730-741. PMID[23405965].

[PubMed]. HIV_0524-060613.

9. A Novel Inhibitor-binding Site on the HIV-1 Capsid N-terminal Domain Leads to Improved Crystallization Via Compound-mediated Dimerization. Lemke, C.T., S. Titolo, N. Goudreau, A.M. Faucher, S.W. Mason, and P. Bonneau. Acta Crystallographica. Section D, Biological Crystallography, 2013. 69(Pt 6): p. 1115-1123. PMID[23695256].

[PubMed]. HIV_0524-060613.

10. 3-Hydroxyphthalic anhydride-modified Human Serum Albumin as a Microbicide Candidate against HIV-1 Entry by Targeting Both Viral Envelope Glycoprotein Gp120 and Cellular Receptor Cd4. Li, M., J. Duan, J. Qiu, F. Yu, X. Che, S. Jiang, and L. Li. AIDS Research and Human Retroviruses, 2013. [Epub ahead of print]. PMID[23711095].

[PubMed]. HIV_0524-060613.

11. Structure and Bioactivity of Triterpenoids from the Stems of Schisandra sphenanthera. Liang, C.Q., R.H. Luo, J.M. Yan, Y. Li, X.N. Li, Y.M. Shi, S.Z. Shang, Z.H. Gao, L.M. Yang, Y.T. Zheng, W.L. Xiao, H.B. Zhang, and H.D. Sun. Archives of pharmacal research, 2013. [Epub ahead of print]. PMID[23703254].

[PubMed]. HIV_0524-060613.

12. Identification and Characterization of a Novel HIV-1 Nucleotide-competing Reverse Transcriptase Inhibitor Series. Rajotte, D., S. Tremblay, A. Pelletier, P. Salois, L. Bourgon, R. Coulombe, S. Mason, L. Lamorte, C.F. Sturino, and R. Bethell. Antimicrobial agents and chemotherapy, 2013. 57(6): p. 2712-2718. PMID[23545531].

[PubMed]. HIV_0524-060613.

13. Viral Infectivity Factor: A Novel Therapeutic Strategy to Block HIV-1 Replication. Yang, G. and X. Xiong. Mini reviews in medicinal chemistry, 2013. 13(7): p. 1047-1055. PMID[23621690].

[PubMed]. HIV_0524-060613.

14. Synthesis and Evaluation of Janus Type Nucleosides as Potential HCV Ns5b Polymerase Inhibitors. Zhou, L., F. Amblard, H. Zhang, T.R. McBrayer, M.A. Detorio, T. Whitaker, S.J. Coats, and R.F. Schinazi. Bioorganic & medicinal chemistry letters, 2013. 23(11): p. 3385-3388. PMID[23623492].

[PubMed]. HIV_0524-060613.

ISI Web of Knowledge Citations

15. Isolation of anti-HIV Components from Canarium album Fruits by High-speed Counter-current Chromatography. Duan, W., S. Tan, J. Chen, S. Liu, S. Jiang, H. Xiang, and Y. Xie. Analytical Letters, 2013. 46(7): p. 1057-1068. ISI[000317340400002].

[WOS]. HIV_0524-060613.

16. The NRTIs Lamivudine, Stavudine and Zidovudine Have Reduced HIV-1 Inhibitory Activity in Astrocytes. Gray, L.R., G. Tachedjian, A.M. Ellett, M.J. Roche, W.-J. Cheng, G.J. Guillemin, B.J. Brew, S.G. Turville, S.L. Wesselingh, P.R. Gorry, and M.J. Churchill. Plos One, 2013. 8(4): p. e62196. ISI[000317893400160].

[WOS]. HIV_0524-060613.

17. Synthesis and anti-HIV-evaluation of Novel Andrographolide Derivatives. Gu, G., H. Lin, Y. Liu, L. Yang, Y. Zheng, B. Wang, C. Tang, H. Qian, and W. Huang. Letters in Drug Design & Discovery, 2013. 10(2): p. 155-163. ISI[000317925100007].

[WOS]. HIV_0524-060613.

18. Identification of Sumoylation Activating Enzyme 1 Inhibitors by Structure-based Virtual Screening. Kumar, A., A. Ito, M. Hirohama, M. Yoshida, and K.Y.J. Zhang. Journal of Chemical Information and Modeling, 2013. 53(4): p. 809-820. ISI[000318060200009].

[WOS]. HIV_0524-060613.

19. Identification of Compounds from the Plant Species Alepidea amatymbica Active against HIV. Louvel, S., N. Moodley, I. Seibert, P. Steenkamp, R. Nthambeleni, V. Vidal, V. Maharaj, and T. Klimkait. South African Journal of Botany, 2013. 86: p. 9-14. ISI[000318055800003].

[WOS]. HIV_0524-060613.

20. Potent and Persistent Activity of a Nucleoside Reverse Transcriptase Inhibitor, 4'-Ethynyl-2-fluoro-2'-deoxyadenosine, against HIV-1 Infection in Langerhans Cells. Matsuzawa, T., T. Kawamura, Y. Ogawa, R. Aoki, Y. Koyanagi, A. Blauvelt, H. Mitsuya, and S. Shimada. Journal of Investigative Dermatology, 2013. 133: p. S197-S197. ISI[000317698901453].

[WOS]. HIV_0524-060613.

21. Scientific Investigation of the anti-HIV Properties of a South African Medicinal Plant. Mbobela, P.F., G. Fouche, C. Kenyon, V. Maharaj, P. Pillay, X. Peter, and N. Van der Berg. South African Journal of Botany, 2013. 86: p. 177-177. ISI[000318055800157].

[WOS]. HIV_0524-060613.

22. Synthesis of Some Novel Thiosemicarbazone Derivatives Having Anti-cancer, anti-HIV as Well as Anti-bacterial Activity. Patel, H.D., S.M. Divatia, and E. de Clercq. Indian Journal of Chemistry Section B-Organic Chemistry Including Medicinal Chemistry, 2013. 52(4): p. 535-545. ISI[000317941600004].

[WOS]. HIV_0524-060613.

23. Design, Synthesis and Antitumor Activity of Novel 4-Methyl-(3'S,4'S)-cis-khellactone Derivatives. Ren, L., X. Du, M. Hu, C. Yan, T. Liang, and Q. Li. Molecules, 2013. 18(4): p. 4158-4169. ISI[000318020100033].

[WOS]. HIV_0524-060613.

24. Discovery of Novel Pyridazinylthioacetamides as Potent HIV-1 NNRTIs Using a Structure-based Bioisosterism Approach. Song, Y.n., P. Zhan, D. Kang, X. Li, Y. Tian, Z. Li, X. Chen, W. Chen, C. Pannecouque, E. De Clercq, and X. Liu. Medchemcomm, 2013. 4(5): p. 810-816. ISI[000318302500016].

[WOS]. HIV_0524-060613.

25. Phomonaphthalenone A: A Novel Dihydronaphthalenone with anti-HIV Activity from Phomopsis Sp Hccb04730. Yang, Z., J. Ding, K. Ding, D. Chen, S. Cen, and M. Ge. Phytochemistry Letters, 2013. 6(2): p. 257-260. ISI[000318271400022].

[WOS]. HIV_0524-060613.

Patent Citations

26. Antiviral Composition. Arsenio do Carmo Sales, M.F., F.S.B. Nuno, B.G. Joao Manuel, and C.S. Ana Catarina. Patent. 2013. 2012-IN153 2013072917: 30pp.

[Patent]. HIV_0524-060613.

27. Preparation of Thiophene Derivatives as HIV Protease Inhibitors. Boyd, M.J., J.-F. Chiasson, S. Crane, and A. Giroux. Patent. 2013. 2012-CA998 2013059928: 127pp.

[Patent]. HIV_0524-060613.

28. Purine Nucleoside Analog Inhibitors of Retroviral Reverse Transcriptase for the Treatment of a Viral Infection and Mutations Associated with Sensitivity to These Inhibitors. Calvez, V., A.-G. Marcelin, C. Soulie, M. Etheve-Quelquejeu, and M. Sollogoub. Patent. 2013. 2012-FR52433 2013060980: 26pp.

[Patent]. HIV_0524-060613.

29. Preparation of Disubstituted Triazine Dimers Useful in the Treatment of Infectious Diseases. Heeres, J., K. Augustyns, P. Van Der Veken, J. Joossens, V. Muthusamy, L. Maes, and P.J. Lewi. Patent. 2013. 2012-EP72308 2013068551: 90pp.

[Patent]. HIV_0524-060613.

30. Preparation of 2-Phenylacetic acid Derivatives as HIV Replication Inhibitors. Iwaki, T. and K. Tomita. Patent. 2013. 2012-JP77544 2013062028: 488pp.

[Patent]. HIV_0524-060613.

31. Peptidomimetic Macrocyclic Peptides for Treating and Preventing HIV Infection and Associated Immune Deficiencies Such as AIDS Disease. Kawahata, N. and C. Elkin. Patent. 2013. 2012-US60919 2013059530: 87pp.

[Patent]. HIV_0524-060613.

32. Preparation of Aminoboronoaminocyclobutylhexanic acid Derivatives and Analogs for Use as Arginase Inhibitors. Van Zandt, M., A. Golebiowski, M.K. Ji, D. Whitehouse, T. Ryder, and R.P. Beckett. Patent. 2013. 2012-US60789 2013059437: 143pp.

[Patent]. HIV_0524-060613.